📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding groove. (2023)

First Author: Tsakok T

Attributed to: MICA: Psoriasis Stratification to Optimise Relevant Therapy (PSORT) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci.insight.156643

PubMed Identifier: 36810251

Publication URI: http://europepmc.org/abstract/MED/36810251

Type: Journal Article/Review

Volume: 8

Parent Publication: JCI insight

Issue: 4

ISSN: 2379-3708